| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $428.5M | +22.5% |
| Cost of Revenue | $98.3M | +27.6% |
| Gross Profit | $330.2M | +21.0% |
| R&D Expense | $160.9M | +19.5% |
| SG&A Expense | $70.0M | +10.9% |
| Operating Income | -$91.1M | -20.6% |
| Pre-tax Income | -$65.8M | -20.7% |
| Income Tax | $3.4M | -49.3% |
| Net Income | -$69.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $49.9M | -41.2% |
| Short-term Investments | $472.1M | +2.6% |
| Accounts Receivable | $90.7M | +18.7% |
| Current Assets | $649.2M | +0.5% |
| Total Assets | $1.13B | +16.2% |
| Current Liabilities | $317.5M | +21.1% |
| Total Liabilities | $356.4M | +21.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $110.9M | +49.6% |
| Capital Expenditures | $3.1M | +58.6% |
| Investing Cash Flow | -$165.4M | -209.2% |
| Financing Cash Flow | $21.2M | +15.6% |
| Free Cash Flow | $107.8M | +49.3% |
| -13.0% |
| EPS (Basic) | -$0.63 | -6.8% |
| EPS (Diluted) | -$0.63 | -6.8% |
| Stockholders' Equity |
| $773.5M |
| +13.9% |